DISTRIBUTION, ELIMINATION AND EFFECT OF FUROSEMIDE IN NORMAL SUBJECTS AND IN PATIENTS WITH HEART-FAILURE

被引：99
作者：
ANDREASEN, F
MIKKELSEN, E
机构：
[1] UNIV AARHUS,INST PHARMACOL,AARHUS,DENMARK
[2] AARHUS KOMMUNE HOSP,DEPT CARDIOL,AARHUS,DENMARK
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1977年 / 12卷 / 01期
关键词：
D O I：
10.1007/BF00561400
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：15 / 22
页数：8
相关论文
共 22 条
[1]  
ANDREASEN F, 1973, ACTA PHARMACOL TOX, V32, P417
[2]  
ANDREASEN F, 1974, ACTA PHARMACOL TOX, V35, P49
[3]   STATISTICAL ESTIMATIONS IN PHARMACOKINETICS [J].
BOXENBAU.HG ;
RIEGELMA.S ;
ELASHOFF, RM .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (02) :123-148
[4]  
CALESNICK B, 1966, P SOC EXP BIOL MED, V123, P17
[5]   INTRAVENOUS ADMINISTRATION OF FUROSEMIDE IN HEART FAILURE [J].
DAVIDOV, M ;
KAKAVIAT.N ;
FINNERTY, FA .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1967, 200 (10) :824-&
[6]   RENAL AND EXTRARENAL HEMODYNAMIC EFFECTS OF FUROSEMIDE IN CONGESTIVE HEART-FAILURE AFTER ACUTE MYOCARDIAL-INFARCTION [J].
DIKSHIT, K ;
VYDEN, JK ;
FORRESTER, JS ;
CHATTERJEE, K ;
PRAKASH, R ;
SWAN, HJC .
NEW ENGLAND JOURNAL OF MEDICINE, 1973, 288 (21) :1087-1090
[7]  
DITLEFSEN EML, 1957, ACTA MED SCAND, V159, P105
[8]  
FOGED L, 1976, ACTA PHARMACOL TOX, V39, P312
[9]  
FORREY AW, 1974, CLIN CHEM, V20, P152
[10]  
GIBALDI M, 1972, J PHARM SCI, V61, P952, DOI 10.1002/jps.2600610630
123